A vaccine to prevent breast cancer being developed by Cleveland Clinic researchers has shown “overwhelmingly favorable results” in animals and could be on its way to conquering the disease that kills more than 40,000 American women each year.Researchers led by Vincent Tuohy, an immunologist at the Clinic’s Lerner Research Institute, have found that a single [...]

Innovation in medical devices. Innovation in vaccines. Even innovation in regulating drug development — MedCity News saw it all last week.

Vince Tuohy was surprised — and grateful — when the National Institutes of Health agreed to back development of his breast cancer vaccine after his first request. Tuohy’s lab at the Cleveland Clinic’s Lerner Research Institute is getting $1.3 million from the National Institutes of Health to continue to develop the vaccine.